Test-retest Evaluation of [18F]F-AraG PET

Clinical trial NCT06084806 · RECRUITING

Trial details

NCT number: NCT06084806
Sponsor: CellSight Technologies, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2023-10-31
Primary completion: 2025-10-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.